Lycopodium clavatum
Lycopodium clavatum · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Lycopodium clavatum is a plant species that has garnered significant scientific interest due to its diverse range of therapeutic activities. Research indicates that its extracts possess potent anticancer and cytotoxic properties, specifically showing promise in the treatment of breast cancer. The plant contains specialized chemicals such as lycopodine and methyl lycernuate A, which contribute to its complex pharmacological profile. Various preparations, including methanol, ethanolic, LC ethanol, and LC water extracts, are utilized to study its potential as an 11B-HSD-inhibitor and 5-alpha-reductase-inhibitor. Furthermore, its antioxidant effects offer potential pathways for addressing neurodegenerative conditions like Alzheimer's disease.
- Synonyms
- Lepidotis Clavata
- Common names
- Not available
- Family
- Lycopodiaceae
- Distribution
- Australasia
- Plant Parts
- Not available
Classification
Common Names
Lycopodium clavatum is a fascinating plant that is known by a diverse array of regional and traditional names. In some areas, it is commonly referred to as Almindelig ulvefod, while others call it Blëtzpolleverkraut. The species also carries several distinct variations of a name that appears to be Cnwbfwsogl Corn Carw. This includes specific linguistic iterations such as Cnwp-Fwsogl Corn Carw and Cnwpfwsogl Corn Carw. Understanding these various monikers helps researchers identify the plant across different cultural and linguistic landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Lycopodium clavatum is a prominent species of clubmoss often recognized for its unique growth patterns and historical uses. In botanical literature, this plant is also frequently referred to by its scientific synonym, Lepidotis clavata. Understanding these taxonomic connections is essential for researchers tracking the evolution of plant naming conventions. While the names may differ depending on the classification system used, they both describe the same biological entity. Recognizing these synonymous relationships ensures clarity and consistency within scientific databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lycopodium clavatum is a fascinating specimen that belongs to the kingdom Plantae. Within this vast botanical realm, it is classified under the class Equisetopsida. This species is further organized into the order Lycopodiales, showcasing its unique evolutionary lineage. It falls under the specific family Lycopodiaceae, which defines its structural characteristics. Ultimately, it is recognized by its distinct genus, Lycopodium, marking its place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Lycopodiidae |
| Order | Lycopodiales |
| Family | Lycopodiaceae |
| Genus | Lycopodium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lycopodium clavatum exhibits a widespread presence across the diverse landscapes of the African continent. Within East Tropical Africa, the species can be found growing in the regions of Kenya, Tanzania, and Uganda. Its distribution also extends into Northeast Tropical Africa, where it thrives in the varied climates of Ethiopia. Additionally, the plant is documented throughout the territories of Sudan and South Sudan. This broad geographic range highlights the plant's ability to adapt to multiple ecological niches across the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lycopodium clavatum is a self-supporting herb that maintains a compact presence on the forest floor. This species typically exhibits a modest growth habit, with heights ranging from a minimum of 0.05 m to a maximum of 0.25 m. While it can be found as small as 0.05 m, it frequently reaches a more standard minimum height of 0.1075 m. Regardless of its specific size within this range, its structure remains sturdy enough to stand without external support. These dimensions characterize the plant's delicate yet resilient botanical profile.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lycopodium clavatum serves as a significant source of secondary metabolites with notable therapeutic potential. Recent research involving methanol extracts of the whole plant has successfully isolated several triterpenoids, including new compounds like lycomclavatols A-C. These specific isolates have demonstrated significant cytotoxic activity against various cancer cell lines, such as HepG2 and A549. This evidence highlights the plant's inherent anticancer properties, which are driven by the biological action of its chemical constituents. Consequently, these findings provide a strong scientific rationale for further investigating the medicinal benefits of this valuable species.
Compounds
Lycopodium clavatum is a significant medicinal plant known for containing a diverse array of bioactive secondary metabolites. Chemical analyses of its extracts have confirmed that the species contains lycopodine, which serves as a major alkaloidal component. In addition to this alkaloid, researchers have identified the presence of methyl lycernuate A within its methanol extracts. These specific compounds contribute to the plant's complex chemical profile and its various biological activities. Understanding these chemical relationships provides a scientific foundation for exploring the plant's potential anti-inflammatory and therapeutic uses.
Conditions
Lycopodium clavatum exhibits significant therapeutic potential, specifically through its ability to treat A549 cancer cell lines via cytotoxic triterpenoids. The plant also treats Alzheimer's disease and related processes by serving as a resource for Huperzine A and demonstrating antioxidant effects. Its alkaloid extracts further contribute to treating Alzheimer's related processes through their demonstrated AChE inhibitory activity in various brain regions. Additionally, the plant treats CYP3A4 MBI, as its ethanolic extracts have been identified as potent mechanism-based inactivators of this enzyme. These diverse biological properties highlight the medicinal versatility of the species in addressing both oncological and neurological conditions.
Preparations
Lycopodium clavatum is prepared as LC Ethanol Extract (LC-EE) and LC Water Extract (LC-WE) to investigate their cytotoxic and apoptotic effects on MCF-7 human breast cancer cells. This plant is also utilized as ethanolic extracts to identify its potential as a potent CYP3A4 mechanism-based inactivator. Research further involves the use of methanol extract from the whole plants to isolate specific triterpenoids and new natural products. Additionally, methanol-extracts of the species have been screened for their ability to demonstrate strong inhibitory activity against Flavobacterium prolyl endopeptidase.